Objective To determine the pooled global prevalence of olfactory and gustatory dysfunction
in patients with the 2019 novel coronavirus (COVID-19). Data Sources Literature searches of …

Objective To study the frequency of neurological symptoms and complications in COVID-19
patients in a systematic review of the literature. Methods Relevant studies were identified …

Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

At the end of 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …

Abstract Background Coronavirus disease 2019 (COVID-19) has become a global
pandemic, affecting millions of people. However, clinical research on its neurological …

Background: Emerging reports suggest that new onset of smell or taste loss are potential
early clinical markers of SARS-CoV-2 infection, but it remains unclear as to what extent …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

The first cases of coronavirus 2019 (COVID-19) occurred in Wuhan, China, and rapidly
become a public health emergency of international proportions. The disease may cause …